SP1 and malignant colon neoplasm: In contrast, one/three consensus Sp1 binding sites between −150/+1 bp of the Klf4 promoter have shown to be important for PDGF- or butyrate-induced Klf4 expression in VSMCs [32], colon cancer cells [25], or odontoblast [33].